Roflumilast--a phosphodiesterase-4 inhibitor licensed for add-on therapy in severe COPD. [electronic resource]
Producer: 20130118Description: w13628 p. digitalISSN:- 1424-3997
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.